Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Matosinhos Municipality
Clinical trial register · Portugal

Clinical Trials in Matosinhos Municipality, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Portugal and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1104 matching records held by the registry are in this view. Synced 30 Oct 2026, 03:17 UTC
1104
Studies in scope
all four open statuses
533
Recruiting now
open to new participants
285
Lead sponsors
across recruiting studies
Top sites
Lisbon 689 Porto 537 Coimbra 256 Braga 182 Vila Nova de Gaia 105
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Amgen7 Sanofi6 Novartis Pharmaceuticals6 AstraZeneca3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2
Site location
Lisbon689 Porto537 Coimbra256 Braga182 Vila Nova de Gaia105
All 97 locations
Target enrolment
to

Trials with a site in Matosinhos Municipality

52 of 1104 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Portugal
Start
Not yet open
Family-centred Pulmonary Rehabilitation to Empower Carers
NCT07791147Pulmonary Disease, Chronic Obstructive, Lung Diseases, Interstitial, Asthma, Lung Neoplasms
Aveiro University
Not applicable
120
Aveiro, Santa Maria da Feira, Figueira da Foz Municipality, Lisbon, Matosinhos Municipality, Vila Nova de Gaia
2026-09
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Amadora-Lisbon, Lisbon, Loures, Matosinhos Municipality, Porto, Vila Nova de Gaia
2026-05-21
Recruiting
AIRNA Corporation
Phase 1
54
Matosinhos Municipality
2026-03-17
Not yet open
Evaluating the Impact of In-Situ Simulation on Interprofessional Healthcare Team Training
NCT07346937in Situ Simulation, Simulation in Training Center
Universidade do Porto
Not applicable
108
Matosinhos Municipality, Porto
2026-02
Recruiting
Eli Lilly and Company
Phase 3
150
Braga, Matosinhos Municipality, Porto, Viana do Castelo, Vila Nova de Gaia
2026-01-12
Recruiting
Hoffmann-La Roche
Phase 3
900
Braga, Coimbra, Funchal, Guimarães, Lisbon, Matosinhos Municipality, Torres Vedras
2025-11-24
Recruiting
Sanofi
Phase 3
942
Almada, Braga, Guimarães, Matosinhos Municipality, Porto
2025-09-16
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Lisbon, Loures, Matosinhos Municipality
2025-08-26
Active, closed
Amgen
Phase 3
350
Lisbon, Matosinhos Municipality
2025-08-18
Active, closed
Amgen
Phase 3
12,800
Braga, Carnaxide, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Ponte de Lima, Riachos, Torres Novas
2025-07-25
Recruiting
Bristol-Myers Squibb
Phase 3
586
Torres Vedras, Matosinhos Municipality, Braga, Coimbra, Guimarães, Porto
2025-07-21
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Almada, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto, Vila Nova de Gaia
2025-06-25
Recruiting
Corxel Pharmaceuticals
Phase 2/3
740
Almada, Braga, Faro, Loures, Matosinhos Municipality
2025-05-15
Recruiting
AstraZeneca
Phase 3
830
Alcabideche, Braga, Coimbra, Lisbon, Loures, Matosinhos Municipality, Porto
2025-04-10
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Almada, Matosinhos Municipality, Vila Nova de Gaia
2025-03-18
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 4
906
Amadora, Coimbra, Funchal, Lisbon, Matosinhos Municipality, Porto
2025-03-14
Active, closed
Sanofi
Phase 3
231
Guimarães, Matosinhos Municipality, Porto, Santa Maria da Feira
2025-02-12
Active, closed
mAbxience Research S.L.
Phase 3
726
Lisbon, Matosinhos Municipality, Porto
2024-12-30
Active, closed
Genmab
Phase 3
191
Coimbra, Matosinhos Municipality, Porto, Setúbal
2024-11-25
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Guimarães, Lisbon, Torres Vedras, Matosinhos Municipality
2024-09-26
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Braga, Coimbra, Lisbon, Matosinhos Municipality, Vila Nova de Gaia
2024-09-26
Recruiting
Bayer
Phase 3
444
Coimbra, Matosinhos Municipality, Lisbon, Porto
2024-08-28
Recruiting
AstraZeneca
Phase 3
788
Coimbra, Lisbon, Matosinhos Municipality, Porto, Vila Real
2024-08-01
Recruiting
Amgen
Phase 3
450
Almada, Coimbra, Lisbon, Matosinhos Municipality, Santa Maria da Feira
2024-07-17
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Coimbra, Lisbon, Matosinhos Municipality
2024-07-12
Active, closed
Celldex Therapeutics
Phase 3
963
Aveiro, Braga, Coimbra, Lisbon, Matosinhos Municipality, Porto, Setúbal, Vila Nova de Gaia
2024-07-11
Active, closed
Amgen
Phase 3
563
Lisbon, Matosinhos Municipality, Porto
2024-06-05
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Braga, Coimbra, Lisbon, Matosinhos Municipality, Santa Maria da Feira
2024-04-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Lisbon, Matosinhos Municipality, Coimbra, Porto
2024-04-03
Recruiting
GlaxoSmithKline
Phase 3
864
Coimbra, Faro, Lisbon, Matosinhos Municipality, Porto, Vila Nova de Gaia
2024-03-21
Active, closed
Sanofi
Phase 3
943
Braga, Lisbon, Matosinhos Municipality
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Braga, Coimbra, Guimarães, Lisbon, Matosinhos Municipality
2023-12-13
Recruiting
Novartis Pharmaceuticals
Observational
174
Amadora, Guimarães, Leiria, Lisbon, Matosinhos Municipality, Ponte de Lima, Porto, Setúbal
2023-11-27
Recruiting
Amgen
Phase 3
750
Lisbon, Matosinhos Municipality, Porto
2023-11-16
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Guimarães, Lisbon, Torres Vedras, Matosinhos Municipality
2023-07-11
Active, closed
Amgen
Phase 3
509
Lisbon, Matosinhos Municipality, Porto
2023-05-31
Active, closed
Gilead Sciences
Phase 3
654
Braga, Guimarães, Lisbon, Matosinhos Municipality
2023-05-08
Recruiting
AstraZeneca
Phase 3
4,300
Amadora, Braga, Guimarães, Lisbon, Matosinhos Municipality, Porto, Vila Nova de Gaia
2023-03-31
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Almada, Carnaxide, Coimbra, Lisbon, Matosinhos Municipality, Porto, Santa Maria da Feira, Setúbal
2023-03-09
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto, Santa Maria da Feira
2023-02-14
Recruiting
Noucor Health S.A.
Phase 1
48
Gaia, Matosinhos Municipality, Porto
2022-11-21
Active, closed
Novartis Pharmaceuticals
Phase 3
95
Matosinhos Municipality, Porto
2022-06-15
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Braga, Coimbra, Leiria, Lisbon, Matosinhos Municipality, Santa Maria da Feira
2021-12-13
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Almada, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto
2021-12-02
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Alcabideche, Almada, Carnaxide, Coimbra, Guimarães, Leiria, Lisbon, Matosinhos Municipality
2021-11-23
Active, closed
Gilead Sciences
Phase 3
603
Coimbra, Lisbon, Matosinhos Municipality, Porto
2021-11-17
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Almada, Lisbon, Matosinhos Municipality, Porto, Setúbal
2021-08-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Lisbon, Matosinhos Municipality, Porto
2021-06-18
Recruiting
Ipsen
Phase 1/2
240
Guimarães, Loures, Matosinhos Municipality, Viana do Castelo
2021-04-29
Active, closed
Daiichi Sankyo
Phase 3
1,600
Guimarães, Lisbon, Loures, Matosinhos Municipality, Porto, Vila Nova de Gaia
2020-12-04
Active, closed
Acerta Pharma BV
Phase 3
611
Braga, Lisbon, Matosinhos Municipality, Porto, Vila Nova de Gaia
2020-10-08
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Braga, Coimbra, Lisbon, Loures, Matosinhos Municipality, Porto, Santa Maria da Feira
2018-12-28
Rows per page Showing 1–52 of 52
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Portuguese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 31 October 2026. https://priyalifescience.com/clinical-trials-portugal/city/matosinhos-municipality

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Portugal and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,104 studies in total at the last sync on 30 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 52 of those studies with a site in Matosinhos Municipality.

How many clinical trials are recruiting in Matosinhos Municipality?

25 of the 52 studies on this page are recruiting new participants as of the 30 Oct 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 25 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Matosinhos Municipality), 52 studies
PhaseStudiesRecruitingShare
Phase 3421780.8%
Not applicable203.8%
Phase 1223.8%
Phase 2/3223.8%
Observational111.9%
Phase 1/2111.9%
Phase 2111.9%
Phase 4111.9%

Most active sponsors

Lead sponsors with the most studies (Matosinhos Municipality)
Lead sponsorStudiesRecruiting
Amgen73
Novartis Pharmaceuticals61
Sanofi61
AstraZeneca33
Gilead Sciences20
Hoffmann-La Roche22
Karuna Therapeutics, Inc., a Bristol Myers Squibb company22
Merck Sharp & Dohme LLC21
Acerta Pharma BV10
AIRNA Corporation11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.